Navigation Links
Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
Date:6/22/2013

ains forward-looking statements about empagliflozin* for the treatment of type 2 diabetes. It reflects Lilly's current beliefs; however, as with any such undertaking, there are substantial risks and uncertainties in the process of drug development and commercialization. There is no guarantee that future study results and patient experience will be consistent with study findings to date or that empagliflozin* will receive regulatory approvals or prove to be commercially successful. For further discussion of these and other risks and uncertainties, please see Lilly's latest Forms 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

CONTACT:

Catherine London
Associate Director, Public Relations
Boehringer Ingelheim Pharmaceuticals, Inc.
Email: usnews@boehringer-ingelheim.com
Phone: (203) 798-4638

Tammy Hull
Communications Manager
Lilly Diabetes
Email: hullta@lilly.com
Phone: (317) 651-9116

References

  1. Hach T, et al. Empagliflozin Improves Glycemic Parameters and Cardiovascular Risk Factors in Patients with Type 2 Diabetes (T2DM): Pooled Data from Four Pivotal Phase III Trials. Poster No. 69-LB. Presented at the American Diabetes Association 73rd Scientific Sessions®. June 21-25, Chicago, IL.
  2. Kim G, et al. Empagliflozin (EMPA) Increases Genital Infections but Not Urinary Tract Infections (UTIs) in Pooled Data from Four Pivotal Phase III Trials. Poster No. 74-LB. Presented at the American Diabetes Association 73rd Scientific Sessions®. June 21-25, Chicago, IL.
  3. Centers for Disease Control and Prevention. Nat
    '/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
2. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
3. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
4. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
5. Safinamide Phase III Study Results Presented at 2013 MDS Meeting
6. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
7. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
8. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
9. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
10. Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
11. Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015  Cyberonics, Inc. (NASDAQ: CYBX ... treatment and management of epilepsy, today announced it will ... March 11, 2015, in Miami . ... Chief Executive Officer, will speak at 1:05 PM Eastern ... chat format, and no formal materials will be presented.  ...
(Date:3/3/2015)... March 3, 2015  The eleventh annual Tucson Symposium ... the world,s top research scientists, academics, oncologists and pathologists ... and learn about new outcomes in patient treatments that ... Each year Ventana Medical Systems, Inc. (Ventana), ... the Tucson Symposium at the Hilton El Conquistador in ...
(Date:3/3/2015)... 3, 2015 /CNW/ - ChipCare Corporation, a University of ... for HIV and other infectious and non-communicable diseases ... to bring its first-generation product to market while ... (Photo: http://photos.prnewswire.com/prnh/20150303/179107 ) ... simple, accurate and affordable diagnostic tests makes it ...
Breaking Medicine Technology:Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2ChipCare Closes Oversubscribed $5 Million Series A Financing 2ChipCare Closes Oversubscribed $5 Million Series A Financing 3
... 23, 2011 Valeant Pharmaceuticals International, Inc. (the "Company" ... Notice of Intention to make a normal course issuer ... that the TSX has accepted the Notice of Intention. ... to purchase for cancellation, commencing August 25, 2011, 1,000,000 ...
... 2011 Bacterin International Holdings, Inc. (NYSE Amex: ... revolutionary bone graft material and antimicrobial coatings for medical applications, ... Annual Global Investment Conference. The conference will be held at ... 11-13, 2011. Bacterin,s chairman and CEO, Guy Cook, ...
Cached Medicine Technology:Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid 2Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid 3Bacterin International to Present at Rodman & Renshaw Annual Global Investment Conference on September 12, 2011 2
(Date:3/3/2015)... (PRWEB) March 03, 2015 A recent ... confirms what water advocate and radio host Sharon Kleyne ... – lack of sufficient water in the body – ... as 90 percent of the US population. Kleyne further ... a factor in nearly all disease, including aging and ...
(Date:3/3/2015)... WA (PRWEB) March 03, 2015 After ... to a lifestyle of fitness and exercise. Community Health ... article presenting 6 ways that families in Everett, ... during the winter months. , CHC says, “While ... grilled chicken and steamed veggies, many families wonder how ...
(Date:3/3/2015)... N.C. (PRWEB) March 03, 2015 ... pre-hire clinical and health care testing, is now ... its behavioral assessments. The result of acquiring the ... provider, PeopleClues in late 2014, the research will ... be used by hospitals, providers, healthcare staffing organizations ...
(Date:3/3/2015)... MO (PRWEB) March 03, 2015 Extend Nutrition, ... to reduce the amount of calories consumed at the next ... “Snack-2-Health Kit.” There are no lifestyle changes needed and ... 2 snacks per day. , The starter kit contains 60 ... a patented blend of protein, fiber, healthy fat and complex ...
(Date:3/3/2015)... NJ (PRWEB) March 03, 2015 Getting to ... when our health and well-being are at stake. So when ... their ability to move about pain-free – it’s vital to ... of this crucial resource, according to Sridhar Yalamanchili, PT, MSPT, ... , A September 2014 nationwide survey by the ...
Breaking Medicine News(10 mins):Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 3Health News:6 Wintertime Weight Loss Tips for Family Fitness Presented by Community Health Center of Snohomish County in Recent Article 2Health News:Prophecy Healthcare Acquires IP to Expand Behavioral Benchmarks 2Health News:Prophecy Healthcare Acquires IP to Expand Behavioral Benchmarks 3Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 2Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 3Health News:Separating Fact from Fiction about Physical Therapy 2Health News:Separating Fact from Fiction about Physical Therapy 3
... it was found that the chest circumference records are beating ... it was found that better nutrition was the main reason. ... that the average chest circumference of Chinese women has increased ... This change was seen only from early 1990s. ...
... most Americans prefer a sandbag workout when compared to a ... brought into focus the latest in fitness craze across the ... a comparable load to what workers of the construction site ... to ‘heave-ho their way to fitness’ by moving around heavy ...
... DTNBP1 that appears to influence human intelligence. This ... manipulation techniques to enhance an individual's intellectual skills. ... of individuals afflicted with schizophrenia; a disorder marked ... with those of normal individuals. This lead to ...
... directed at B-cells could turn out be more effective ... disease arising out of an auto immune disorder.// ... form of biologic therapy for treatment of rheumatoid arthritis ... patients who exhibit resistance to conventional DMARDs. The effect, ...
... researchers at Columbia University Medical Center to analyze the ... cancer treatment, //it has been found that nearly one ... specifically, stage III colon cancer patients who were prescribed ... were found to stop their treatment before completion. ...
... Many of Britain’s workers frequently report sick due to ... to 3000 people develop// occupational asthma every year. Prolonged ... trigger occupational asthma. ,Alveolitus or 'occupational asthma’ is ... an allergic inflammation of the lung. It is ...
Cached Medicine News:Health News:Human Intelligence Gene Identified By Scientists 2Health News:B-Cell Biologic Therapy Could Revolutionize Rheumatoid Arthritis Treatment 2Health News:B-Cell Biologic Therapy Could Revolutionize Rheumatoid Arthritis Treatment 3Health News:Colon Cancer Death Rate Doubles As Patients Stop Chemotherapy 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: